Security readout for executives and security teams
Plain-English summary
CVE-2022-37830 reports cross-site scripting in Interway a.s WebJET CMS 8.6.896. The source bundle does not provide CVSS, affected version ranges beyond 8.6.896, exploit status, or a named patch. Treat this as a validation item for any WebJET CMS deployment rather than assuming broad exposure.
Executive priority
Investigate promptly if WebJET CMS is used, especially on public or business-critical sites. Urgency is uncertain because severity and exploitation evidence are missing.
Technical view
The public CVE description identifies XSS in WebJET CMS 8.6.896. It does not specify stored versus reflected behavior, the affected endpoint, required privileges, user interaction, or remediation. No CPEs, CWE mapping, CVSS vector, or KEV listing are provided in the bundle.
Likely exposure
Likely limited to organizations running Interway a.s WebJET CMS 8.6.896. Exposure cannot be broadened to other versions from the supplied evidence.
Exploitation context
The bundle does not show active exploitation, public exploit availability, or KEV inclusion. XSS risk usually depends on reachable vulnerable functionality, user interaction, session context, and browser-side impact.
Researcher notes
Key missing data: endpoint, XSS type, attacker prerequisites, user interaction, CVSS, CWE, and fixed version. Avoid extrapolating beyond WebJET CMS 8.6.896 unless vendor or advisory evidence supports it.
Mitigation direction
- Inventory WebJET CMS deployments and confirm whether version 8.6.896 is present.
- Review Interway/WebJET and Citadelo guidance for any supported patch or upgrade path.
- Prioritize remediation for internet-facing or authenticated CMS surfaces handling sensitive sessions.
- Apply temporary access restrictions where CMS exposure is not operationally required.
Validation and detection
- Check asset records and application banners for WebJET CMS 8.6.896.
- Review the Citadelo PDF for component-level details before testing.
- Verify whether vendor release notes mention CVE-2022-37830 remediation.
- Confirm no assumption of other affected versions without vendor evidence.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CVE-2022-37830 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
SSVC decision data
Vulnerability timeline
Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.
- CVE reservedCVE Program
The CVE ID was reserved by the assigning CNA.
- CVE publishedCVE Program
The CVE record was published.
- CVE updatedCVE Program
The CVE record metadata indicates this as the latest update time.
ADP provider summaries
Source materials
- CVE List V5 sourceCVE List V5
- https://citadelo.com/download/CVE-2022-37830.pdfCVE reference, mitre
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.